top of page

  Research Database  

  Approaching innovative ray  

CHEARS Logo.jpg
Research ID :

9669aaad-665f-4f35-8e01-1e9d11441694

Assessment of cancer stigma using validated Cancer Stigma Scale in general population

Investigator :

Umme Habeeba A Pathan

Status of study

Title Approval 

5b321dd937b49c6b5cc6ace5_pending.gif

Protocol

5b321dd937b49c6b5cc6ace5_pending.gif

Mid term Report

5b321dd937b49c6b5cc6ace5_pending.gif

Final Report

5b321dd937b49c6b5cc6ace5_pending.gif

Health related stigma is found in highly transmissible diseases like HIV/AIDS, Leprosy and mental illness. Research in cancer related stigma is very less in India because of the reason of not asking the right question. This study is an attempt to investigate whether the cancer related stigma exist using validated CASS conducted by Marlow LAV et al in 2014. This scale was also implemented in the Japanese population in 2020. Being able to measure the stigma of cancer would make it possible to identify the extent to which stigma exists.

This study was conducted for the first time by implementing CASS in general population of India. There were many similarities and dissimilarities to the original CASS. The properties of CASS were implemented in general population of India. The study was conducted on lesser population and hence further studies with large population are needed due to varied diversity of India.


-------------------------

1. Bethesda. Understanding cancer. National Institutes of Health. 2007. Available from: https://www.ncbi.nlm.nih.gov/books/NBK20362/#_NBK20362_pubdet_

2. Takeuchi E, Fujisawa D, Miyawaki R, Yako-Suketoma H, Oka K, Mimura M et al. Cross-culture validation of the Cancer Stigma Scale in the general Japanese population. Palliat Support Care. 2020; 1-7. Available from: doi:10.1017/S1478951520000486.

3. Vrinten C, Gallagher A, Waller J, Marlow LAV. Cancer Stigma and cancer screening attendance: a population based survey in England. BMC Cancer. 2019; 19(566). Available from: doi: 10.1186/s12885-019-5787-x.

4. Longo DL. Approach to the patient with cancer. In: Harrison TR, Kasper DL, Hauser SL (eds.) Harrison’s Principles of Internal Medicine. 19th edition. United States of America: McGraw Hill Education; 2012. p. 467-75.

5. Stangl AL, Earnshaw VA, Logie CH, Brakel WV, Simbayi LC, Barre I et al. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019; 17(31). Available from: doi: 10.1186/s12916-019-1271-3.

6. Marlow LAV, Wardle J. Development of a scale to assess cancer stigma in the non-patient population. BMC Cancer. 2014; 14(285). Available from: https://www.biomedcentral.com/1471-2407/14/285.

7. Doganavsargil-Baysal O, Senol Y, Coskun HS. Cancer stigma scale: validity and reliability of the Turkish version of the Cataldo Lung Cancer Stigma Scale for all cancer subtypes. J Oncol Sci. 2019: 105-8. Available from: doi: 10.1016/j.jons.2019.09.001.

8. Ahmad MM, Musallam R, Allah AH, Al-Daken LA, Abu-Snieneh H, Al-Dweik G. Maturity level of the stigma concept associated with cancer diagnosis in the nursing literature. Asian Pac J Cancer Prev. 2018; 19(2): 497-85. Available from: doi: 10.22034/APJCP.2018.19.2.479.

bottom of page